• Muhammed Ali w/Maholon DeLong

    Blog: Dana Alliance Members Awarded Lasker Clinical Research Award

    The Lasker Foundation announced that two scientists, one a European Dana Alliance member and the other a Dana Alliance member, will share the 2014 Lasker~DeBakey Clinical Medical Research Award. The award recognizes the work of Alim Louis Benabid and Mahlon R. DeLong to develop deep brain stimulation. Dr. DeLong has been the author or the subject of several Dana stories; see a sample on our blog.

    Read Our Blog
  • Cerebrum - Sep 2014 - book cover - feature

    Cerebrum Book Reviews: Truth, Justice, and the NFL Way

    Our reviewer, Philip E. Stieg, a neuro-trauma consultant on the sidelines of NFL games, is no stranger to the violence of football. In his review of League of Denial by Mark Fainaru-Wada and Steve Fainaru, Stieg finds the sports-concussion crisis to be a difficult subject.

    Read review
  • Design_a_Brain_Experiment_logo

    Students: Design a Brain Experiment

    The Dana Foundation is asking U.S. high school students to submit their most creative brain experiment ideas to the fourth annual Design a Brain Experiment Competition. Submissions must test an idea about the brain, anything from examining the effects of art on the adolescent brain to exploring alternative treatments for Alzheimer's disease. Students should not complete their experiments, so be creative!

    See story
  • FENS14-award-slider

    Three Win Awards for Neuroscience Outreach

    Dr. Mara Dierssen (Spain), Mary Baker MBE (UK), and the Hellenic Society for Neuroscience (Greece) will be awarded prestigious prizes linked to their outreach efforts on behalf of neuroscience. The awards were presented during the FENS Forum in July.

    More information
  • SS-Mandarin-May2014

    Staying Sharp Mandarin Inspires More Events

    The first-ever Staying Sharp program in Mandarin was such a success that the Foundation is working with local partners and senior centers in other Mandarin-speaking communities in New York to present a series of mini-Staying Sharp sessions. Sessions will start later this month and run for the rest of the year. 

    More information

Top Stories

Target: Tau

by Jim Schnabel

Scientists have new insights into how the tau protein spreads within and harms the brain, in Alzheimer’s and other diseases--and tau-targeting therapies are now entering clinical trials.

Placebo Effects Offer Window to Individual Differences in Treatment Response

By Jon-Kar Zubieta, MD, PhD

Rather than discounting placebo responses as irrelevant noise, we should instead investigate them as predictors of treatment response and as novel therapeutic targets in medication, device, or psychotherapeutic approaches to disease recovery. One of our series of Reports on Progress.

The Brain Inflamed

by Jim Schnabel

Scientists are finding evidence that neuroinflammation can alter mood and cognition, perhaps enough to help cause psychiatric disorders.

A Victory for Clinician Scientists

by Guy McKhann, MD

Guy_McKhann_thmbRecipients of a Lasker Award this year, Alim Louis Benabid and Mahlon DeLong are the epitome of clinical scientists, going from the patient to the laboratory and back to the patient. Clinical scientists just getting started in their careers can learn from them. From our free print publication, Brain in the News.

Taking Out The Garbage: New Hope for Treating Neurodegeneration

by Kayt Sukel

Dementias, ALS, and Huntington’s show different outward symptoms, but researchers theorize the disease process may be similar—a buildup of proteins that normally are cleared away.

More Evidence That Vitamin D Protects Against Alzheimer’s

by Jim Schnabel

Lower vitamin D levels linked to higher dementia risk in two separate studies.

Autism Remains a Mystery, but Help May Be on the Horizon

AAAS Capitol Hill Briefing

As autism prevalence rises, early behavioral intervention is key, experts say, and insights on brain signaling could lead to new treatments. A report from a Capitol Hill briefing in July. See also links to video of the briefing.

The Neurobiology of Resilience

Brenda Patoine

Most drug development for depression has focused on undoing the bad effects of stress, but new research suggests that finding ways to induce resilience could lead to new treatments. One of our series of Briefing Papers.


With A Little Help from Our Friends: How the Brain Processes Empathy

October 1, 2014

by Peggy Mason, PhD 

 Cerebrum - article - August 2014 - feature

Why are certain individuals born with a brain that is wired to help others? What daily habits or life experiences reinforce compassion but also selfishness, narcissism, and psychopathy? A better understanding of the neurobiological underpinnings for how the brain processes empathy could lead to more social cohesion and less antisocial harm in society.

Stay In Touch

Sign up for the monthly Cerebrum newsletter, or the twice-monthly News and Features newsletter.

Featured Publication

You've Got Some Explaining to Do

You've Got Some Explaining to Do offers advice specifically for neuroscientists writing for non-scientists, including targeting your audience, organizing your thoughts, and avoiding jargon and negative wording. $2.99 in paperback; PDF version is free.

Featured Video

Stressing about Stress: Scientists Janice Kiecolt-Glaser of Ohio State and David Shurtleff of NIH help us better understand what our mind and body experience—good and bad—when we encounter stressful situations during an evening at AAAS in Washington, DC, on Sept. 18, 2014.